Cardiac Regeneration strategies: Staying young at Heart
The heart tissue of mammals has
the limited capacity to regenerate after an injury such as a heart attack or
cardiac injuries in part due to the inability to reactivate a cardiac muscle
cell and proliferation. Generally injured hearts do not heal themselves.
Cardiac muscle cells or cardiomyocytes do not proliferate as much as necessary
to replace dead tissue with new, pumping cells. Therefore, most people who had a severe heart
attack or other injury related to the heart, will develop heart failure and
that’s the leading reason of mortality from Heart Diseases.
As we know that cell
proliferation is much essential for the tissue regeneration and cardiomyocytes
are highly specialized cells which involves in maintaining the pumping of
heart. In previous findings it has been proved that the Hippo pathway stops the
Proliferation of cardiomyocytes by inhibiting the activity of YAP pathway. For
the reason, a mouse model was developed expressing the adult cardiomyocytes
with a version of YAP (YAP5SA) that is impervious to the inhibitory influence
of Hippo. By expressing YAP5SA, we could reprogram these specialized adult cardiomyocytes.
The reprogrammed cells can also proliferate and new cells can make connections
with the existing cardiomyocytes. In this way we can improve Heart
Tissue regeneration.
The alternate solution for
damaged or lost myocardium describes the derivation of stem cells from cardiomyocytes
and their transplantation. Stem
cell therapies using adult stem cells and pluripotent stem cells are the new
approaches that could potentially achieve the goal of true cardiac regeneration.
Over the past two decades,
various stem cell based approaches have been shown to improve left ventricular
function in pre-clinical animal model trials. This has been shown to be safe
and have advanced our understanding of potential suitable recipients and
possible mechanisms of action. However, efficacy in these trials has been
inconsistent. Human pluripotent stem cells (hPSCs) are another potential source
of stem cells for the cardiac regeneration. They could theoretically provide an
unlimited source of cardiomyocytes or progenitor for cardiac tissue.
Pre-clinical studies in both small and large animal models have shown robust
engraftment and improvements in cardiac function.
Comments
Post a Comment